◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

Xenetic Biosciences, Inc.

CIK: 1534525 SIC: 2834
$2.98M
Revenue
$-2.68M
Net Income
-
Gross Margin
-95.23%
Op. Margin
$-4.67M
Free Cash Flow
Financial Statements Quarterly (10-Q)
Showing 7 of 42 quarterly reports available
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
+ Total Revenue $766.30K $1.03M $589.90K $593.26K $648.82K $614.24K $726.40K
Revenue Growth % (YoY) 18.1% 67.2% -18.8% nan% nan% nan% nan%
Operating Expenses $1.39M $1.57M $1.31M $1.54M $1.75M $1.11M $2.06M
Research & Development $773.42K $756.48K $656.56K $879.03K $1.04M $367.99K $933.77K
+ Operating Income $-623.03K $-544.73K $-724.41K $-942.41K $-1.10M $-499.47K $-1.34M
Operating Margin % -81.3% -53.0% -122.8% -158.9% -169.4% -81.3% -184.1%
Interest Expense - - - - - - -
Other Income/Expense $159.00 $4.01K $1.48K $78.00 $-7.24K $1.50K $-21.00
+ Net Income $-579.08K $-509.94K $-688.70K $-903.14K $-1.05M $-436.67K $-1.27M
Net Margin % -75.6% -49.7% -116.7% -152.2% -162.5% -71.1% -175.4%
Basic EPS nan -0.33 -0.45 -0.59 -0.68 -0.28 -0.83
Diluted EPS nan -0.33 -0.45 -0.59 -0.68 -0.28 -0.83
Basic Shares Outstanding 159K 1.5M 1.5M 1.5M 269 1.5M 1.5M
Diluted Shares Outstanding 159K 1.5M 1.5M 1.5M 269 1.5M 1.5M
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Cash & Cash Equivalents - - - $5.16M $6.17M $6.84M $7.30M
Other Current Assets $166.29K $946.36K $573.85K $313.62K $421.95K $188.09K $716.38K
Total Current Assets $8.05M $5.07M $5.35M $5.48M $6.59M $7.03M $8.01M
Other Non-current Assets $313.92K - - $313.92K $313.92K $1.02M $1.02M
Total Assets $8.36M $5.07M $5.35M $5.79M $6.90M $8.05M $9.03M
Accounts Payable $258.11K $578.25K $346.83K $240.29K $283.62K $243.34K $283.59K
Accrued Liabilities $709.92K - - - $610.65K - -
Total Current Liabilities $968.02K $1.11M $903.43K $667.93K $894.26K $1.01M $1.59M
Total Liabilities $968.02K $1.11M $903.43K $667.93K $894.26K $1.01M $1.59M
Common Stock $2.29K $1.54K $1.54K $1.54K $1.54K $1.54K $1.54K
Retained Earnings $-199.88M $-199.30M $-198.79M $-198.10M $-197.19M $-196.14M $-195.70M
Total Stockholders Equity $7.40M $3.96M $4.45M $5.12M $6.01M $7.04M $7.45M
Total Liabilities & Equity $8.36M $5.07M $5.35M $5.79M $6.90M $8.05M $9.03M
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Net Income $-579.08K $-509.94K $-688.70K $-903.14K $-1.05M $-2.91M $-1.27M
Stock-based Compensation - - - - - - $42.10K
Operating Cash Flow $-242.68K $-2.04M $-1.39M $-1.00M $-673.99K $-2.14M $-1.68M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $1.03M $614.24K $2.21M $1.85M
Operating Expenses $1.57M $1.11M $4.42M $4.96M
Research & Development $756.48K $367.99K $2.29M $2.25M
Operating Income $-544.73K $-499.47K $-2.21M $-3.11M
Interest Expense - - - -
Other Income/Expense $4.01K $1.50K $5.57K $1.53K
Net Income $-509.94K $-436.67K $-2.10M $-2.91M
Basic EPS -0.33 -0.28 -1.36 -1.89
Diluted EPS -0.33 -0.28 -1.36 -1.89
Basic Shares Outstanding $1.54M $1.54M $1.54M $1.54M
Diluted Shares Outstanding $1.54M $1.54M $1.54M $1.54M
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Other Current Assets $946.36K $421.95K
Total Current Assets $5.07M $6.59M
Other Non-current Assets - $313.92K
Total Assets $5.07M $6.90M
Accounts Payable $578.25K $283.62K
Total Current Liabilities $1.11M $894.26K
Total Liabilities $1.11M $894.26K
Common Stock $1.54K $1.54K
Retained Earnings $-199.30M $-197.19M
Total Stockholders Equity $3.96M $6.01M
Total Liabilities & Equity $5.07M $6.90M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-509.94K $-436.67K $-2.10M $-2.91M
Operating Cash Flow - - $-2.04M $-2.14M

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.

Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...